title: Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone.
abstract: Melanocytes synthesise two types of melanin: the brown-black eumelanin and the red-yellow phaeomelanin. In mice, the relative proportions of these two melanins are regulated by alpha-MSH, which preferentially increases the synthesis of eumelanin and by the Agouti protein (AP), the expression of which correlates with the growth of yellow phaeomelanin-containing hair. It has been proposed that AP acts by antagonizing the action of alpha-MSH at the MC1 receptor, although it has been suggested that it may also act independently of alpha-MSH. In the present study we show that AP inhibits melanogenesis in B16F1 melanoma cells in the presence and absence of alpha-MSH and also causes dose-related decreases in the synthesis of both eumelanin and phaeomelanin. In the presence of alpha-MSH AP had a greater effect on eumelanin production and this is consistent with an antagonistic action at the MC1 receptor. In the absence of alpha-MSH however, AP produced similar reductions in the synthesis of both melanins. These changes were not seen in B16G4F cells which lack the MC1 receptor, suggesting that even in the absence of alpha-MSH AP acts at the MC1 receptor. How this action is mediated at the intracellular level is not yet clear, although it appears to be associated with a decrease in tyrosinase activity.
authors.affiliation: Department of Dermatology, University of Newcastle upon Tyne, United Kingdom.
authors.forename: A
authors.initials: A
authors.lastname: Graham
authors.forename: K
authors.initials: K
authors.lastname: Wakamatsu
authors.forename: G
authors.initials: G
authors.lastname: Hunt
authors.forename: S
authors.initials: S
authors.lastname: Ito
authors.forename: A J
authors.initials: AJ
authors.lastname: Thody
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D054366:Agouti Signaling Protein; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003994:Bucladesine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D036341:Intercellular Signaling Peptides and Proteins; D008543:Melanins / Q000096:biosynthesis*; D008545:Melanoma; D051379:Mice; D011506:Proteins / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000201:enzymology; D000521:alpha-MSH / Q000494:pharmacology*
chemical_list: D054366:Agouti Signaling Protein; D000970:Antineoplastic Agents; D036341:Intercellular Signaling Peptides and Proteins; D008543:Melanins; D011506:Proteins; C515183:a protein, mouse; C016042:phaeomelanin; C041877:eumelanin; D000521:alpha-MSH; D003994:Bucladesine; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D002118:Calcium